Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Turunen, Sanna ^a   Koivula, Marja Kaisa ^a,b   Melkko, Jukka ^a,b   Alasaarela, Eeva ^b   Lehenkari, Petri ^a,b   Risteli, Juha ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autoantibodies; Carbamylation; Citrulline; Homocitrulline; Rheumatoid arthritis; Tissue

Indexed keywords

CARBOXYTELOPEPTIDE; CITRULLINATED PROTEIN ANTIBODY; CITRULLINE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; HOMOCITRULLINE; LEFLUNOMIDE; METHOTREXATE; NATRIUMAUROTHIOMALATE; PREDNISOLONE; PROTEIN ANTIBODY; TELOPEPTIDE; THIOMALIC ACID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOT; FOOT SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SYNOVITIS; TISSUE LEVEL;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; FEMALE; FOOT JOINTS; HUMANS; MIDDLE AGED; PROTEIN BINDING;

EID: 84884407695     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-224     Document Type: Article

References (20)

1. Koivula MK, Heliovaara M, Ramberg J, Knekt P, Rissanen H, Palosuo T, Risteli J. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis. Ann Rheum Dis 2007, 66:1450-1455. 10.1136/ard.2006.062919, 2111613, 17472989.
2. Lundberg K, Nijenhuis S, Vossenaar ER, Palmblad K, van Venrooij WJ, Klareskog L, Zendman AJ, Harris HE. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005, 7:R458-R467. 10.1186/ar1697, 1174941, 15899032.
3. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018, 14872479.
4. Suwannalai P, Trouw LA, Toes RE, Huizinga TW. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol 2012, 22:15-20. 10.1007/s10165-011-0486-8, 21732051.
5. van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, van Schaardenburg D. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum 2011, 63:3226-3233. 10.1002/art.30537, 21792832.
6. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, Mikuls TR, Venables PJ. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008, 58:3009-3019. 10.1002/art.23936, 18821669.
7. Koivula MK, Aman S, Karjalainen A, Hakala M, Risteli J. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?. Ann Rheum Dis 2005, 64:1443-1450. 10.1136/ard.2004.031211, 1755220, 16162901.
8. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166:4177-4184.
9. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 2011, 108:17372-17377. 10.1073/pnas.1114465108, 3198314, 21987802.
10. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46. 10.1002/art.21575, 16385494.
11. Nesse W, Westra J, van der Wal JE, Abbas F, Nicholas AP, Vissink A, Brouwer E. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 2012, 39:599-607. 10.1111/j.1600-051X.2012.01885.x, 22530757.
12. Turunen S, Koivula MK, Risteli L, Risteli J. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum 2010, 62:3345-3352. 10.1002/art.27644, 20617522.
13. Koivula MK, Aman S, Alasaarela E, Karjalainen A, Hakala M, Risteli J. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:1364-1369.
14. Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012, 122:1791-1802. 10.1172/JCI60975, 3336988, 22505457.
15. Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Mechin MC, Vincent C, Nachat R, Yamada M, Takahara H, Simon M, Guerrin M, Serre G. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007, 56:3541-3553. 10.1002/art.22983, 17968929.
16. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:40-50.
17. Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 2013, Published online first, doi:10.1136/annrheumdis-2012-202958.
18. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007, 13:1176-1184. 10.1038/nm1637, 17828273.
19. Jaisson S, Gillery P. Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins. Clin Chem 2010, 56:1401-1412. 10.1373/clinchem.2010.145201, 20562349.
20. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ. NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis. Sci Transl Med 2013, 5:178ra40. 10.1126/scitranslmed.3005580, 23536012.